Headlines

Silicon Motion Technology Corporation And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Silicon Motion Technology Corporation (SIMO), Mercury General Corporation (MCY), Insulet (PODD) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Silicon Motion Technology Corporation (SIMO)

33.3% sales growth and 7.21% return on equity

Silicon Motion Technology Corporation, together with its subsidiaries, designs, develops, and markets NAND flash controllers for solid-state storage devices. It offers controllers for computing-grade solid state drives (SSDs), which are used in PCs and other client devices; enterprise-grade SSDs used in data centers; eMMC and UFS mobile embedded storage for use in smartphones and IoT devices; flash memory cards and flash drives for use in expandable storage; and specialized SSDs that are used in industrial, commercial, and automotive applications. It markets its controllers under the SMI brand; enterprise-grade SSDs under the Shannon Systems brand; and single-chip industrial-grade SSDs under the Ferri SSD, Ferri-eMMC, and Ferri-UFS brands. The company markets and sells its products through direct sales personnel and independent electronics distributors to NAND flash makers, module makers, hyperscalers, and OEMs. It operates in Taiwan, the United States, South Korea, China, Malaysia, Singapore, and internationally. Silicon Motion Technology Corporation was founded in 1995 and is based in Hong Kong, Hong Kong.

Earnings Per Share

As for profitability, Silicon Motion Technology Corporation has a trailing twelve months EPS of $1.58.

PE Ratio

Silicon Motion Technology Corporation has a trailing twelve months price to earnings ratio of 45.41. Meaning, the purchaser of the share is investing $45.41 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.21%.

2. Mercury General Corporation (MCY)

20.2% sales growth and 6.28% return on equity

Mercury General Corporation, together with its subsidiaries, engages in writing personal automobile insurance in the United States. It also writes homeowners, commercial automobile, commercial property, mechanical protection, fire, and umbrella insurance. The company's automobile insurance products cover collision, property damage, bodily injury, comprehensive, personal injury protection, underinsured and uninsured motorist, and other hazards; and homeowners' insurance products cover dwelling, liability, personal property, fire, and other hazards. It sells its policies through a network of independent agents, 100% owned insurance agents, and direct channels in Arizona, California, Florida, Georgia, Illinois, Nevada, New Jersey, New York, Oklahoma, Texas, and Virginia. The company was founded in 1961 and is headquartered in Los Angeles, California.

Earnings Per Share

As for profitability, Mercury General Corporation has a trailing twelve months EPS of $1.74.

PE Ratio

Mercury General Corporation has a trailing twelve months price to earnings ratio of 27.98. Meaning, the purchaser of the share is investing $27.98 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.28%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Mar 12, 2024, the estimated forward annual dividend rate is 1.27 and the estimated forward annual dividend yield is 2.61%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 19.9%, now sitting on 4.63B for the twelve trailing months.

Yearly Top and Bottom Value

Mercury General Corporation’s stock is valued at $48.69 at 11:22 EST, under its 52-week high of $52.42 and way above its 52-week low of $26.15.

3. Insulet (PODD)

19% sales growth and 34.13% return on equity

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Earnings Per Share

As for profitability, Insulet has a trailing twelve months EPS of $2.94.

PE Ratio

Insulet has a trailing twelve months price to earnings ratio of 62.15. Meaning, the purchaser of the share is investing $62.15 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.13%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 37.9%, now sitting on 1.7B for the twelve trailing months.

4. STERIS (STE)

14.3% sales growth and 9.11% return on equity

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Earnings Per Share

As for profitability, STERIS has a trailing twelve months EPS of $5.68.

PE Ratio

STERIS has a trailing twelve months price to earnings ratio of 41.22. Meaning, the purchaser of the share is investing $41.22 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.11%.

Moving Average

STERIS’s value is higher than its 50-day moving average of $224.37 and above its 200-day moving average of $218.86.

5. Ceragon Networks Ltd. (CRNT)

13.9% sales growth and 4.9% return on equity

Ceragon Networks Ltd. provides wireless backhaul solutions that enable cellular operators and other wireless service providers to deliver voice and data services. Its wireless backhaul solutions use microwave and millimeter wave technology to transfer telecommunication traffic between base stations, small/distributed cells, and the core of the service provider's network. The company also offers wireless fronthaul solutions that use microwave technology for ultra-high speed, ultra-low latency communication for wireless 5G and 4G base stations. In addition, it provides IP-20 all-outdoor solutions, such as IP-20C, IP-20C-HP, IP-20S, IP-20E, and IP-20V; IP-20 split-mount/all-indoor solutions comprising IP-20N/IP-20A, IP-20F, and IP-20G; and IP-50 disaggregated solutions, including IP-50E, IP-50C, IP-50S, and IP-50FX for various short-haul, long-haul, fronthaul, and enterprise access applications. Further, the company offers network management system; and network and radio planning, site survey, solutions development, installation, network auditing and optimization, maintenance, training, and other services. It provides its services to smart-phone applications, such as internet browsing, social networking, image sharing, music, and video applications; oil and gas companies; public safety organizations; business and public institutions; broadcasters; energy utilities; and private communications networks. The company sells its products through direct sales, original equipment manufacturers, resellers, distributors, and system integrators. It operates in North America, Europe, Africa, the Asia Pacific, the Middle East, India, and Latin America. The company was formerly known as Giganet Ltd. and changed its name to Ceragon Networks Ltd. in September 2000. Ceragon Networks Ltd. was incorporated in 1996 and is headquartered in Tel Aviv, Israel.

Earnings Per Share

As for profitability, Ceragon Networks Ltd. has a trailing twelve months EPS of $0.07.

PE Ratio

Ceragon Networks Ltd. has a trailing twelve months price to earnings ratio of 43. Meaning, the purchaser of the share is investing $43 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.9%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Ceragon Networks Ltd.’s EBITDA is 22.47.

Sales Growth

Ceragon Networks Ltd.’s sales growth is 4.8% for the present quarter and 13.9% for the next.

Yearly Top and Bottom Value

Ceragon Networks Ltd.’s stock is valued at $3.01 at 11:22 EST, below its 52-week high of $3.15 and way higher than its 52-week low of $1.55.

6. Churchill Downs (CHDN)

10% sales growth and 57.75% return on equity

Churchill Downs Incorporated operates as a racing, online wagering, and gaming entertainment company in the United States. It operates through three segments: Live and Historical Racing, TwinSpires, and Gaming. As of December 31, 2021, the company owned and operated three pari-mutuel gaming entertainment venues with approximately 3,050 historical racing machines (HRMs) in Kentucky; TwinSpires, an online wagering platform for horse racing, sports, and iGaming; nine retail sportsbooks; and casino gaming in eight states with approximately 11,000 slot machines and video lottery terminals, and 200 table games. It also offers streaming video of live horse races, replays, and an assortment of racing and handicapping information; and provides the Bloodstock Research Information Services platform for horse racing statistical data. In addition, the company manufactures and operates pari-mutuel wagering systems for racetracks, off-track betting facilities, and other pari-mutuel wagering businesses. Churchill Downs Incorporated was founded in 1875 and is headquartered in Louisville, Kentucky.

Earnings Per Share

As for profitability, Churchill Downs has a trailing twelve months EPS of $5.49.

PE Ratio

Churchill Downs has a trailing twelve months price to earnings ratio of 21.21. Meaning, the purchaser of the share is investing $21.21 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 57.75%.

7. Canadian Pacific Railway (CP)

7.9% sales growth and 9.65% return on equity

Canadian Pacific Kansas City Limited, together with its subsidiaries, owns and operates a transcontinental freight railway in Canada, the United States, and Mexico. The company transports bulk commodities, including grain, coal, potash, fertilizers, and sulphur; merchandise freight, such as forest products, energy, chemicals and plastics, metals, minerals, consumer products, and automotive; and intermodal traffic comprising retail goods in overseas containers. It also provides rail and intermodal transportation services over a network of approximately 20,000 miles serving business centres. The company was formerly known as Canadian Pacific Railway Limited and changed its name to Canadian Pacific Kansas City Limited in April 2023. Canadian Pacific Kansas City Limited was incorporated in 1881 and is headquartered in Calgary, Canada.

Earnings Per Share

As for profitability, Canadian Pacific Railway has a trailing twelve months EPS of $3.11.

PE Ratio

Canadian Pacific Railway has a trailing twelve months price to earnings ratio of 28.96. Meaning, the purchaser of the share is investing $28.96 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.65%.

8. BlackRock Capital Investment Corporation (BKCC)

6.2% sales growth and 4.85% return on equity

BlackRock Capital Investment Corporation, formerly known as BlackRock Kelso Capital Corporation, is a Business Development Company specializing in investments in middle market companies. The fund invests in all industries. It prefers to invest between $10 million and $50 million and can invest more or less in companies with EBITDA or operating cash flow between $10 million and $50 million. The fund invests in the form of senior and junior secured, unsecured, and subordinated debt securities and loans including cash flow, asset backed, and junior lien facilities and equity securities. It's equity investments can be structured in the form of warrants, preferred stock, common equity co-investments, and direct investments in common stock. The fund's debt investments are principally structured to provide for current cash interest and to a lesser extent non-cash interest, particularly with subordinated debt investments, through a pay-in-kind (PIK) feature. It can also make non-control investments.

Earnings Per Share

As for profitability, BlackRock Capital Investment Corporation has a trailing twelve months EPS of $0.22.

PE Ratio

BlackRock Capital Investment Corporation has a trailing twelve months price to earnings ratio of 16.73. Meaning, the purchaser of the share is investing $16.73 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.85%.

Sales Growth

BlackRock Capital Investment Corporation’s sales growth is 14.9% for the current quarter and 6.2% for the next.

Volume

Today’s last reported volume for BlackRock Capital Investment Corporation is 526092 which is 140.52% above its average volume of 218728.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Dec 14, 2023, the estimated forward annual dividend rate is 0.4 and the estimated forward annual dividend yield is 10.81%.

Leave a Reply

Your email address will not be published. Required fields are marked *